CardioMEMS European Monitoring Study for Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 239 participants.

Also called NCT02693691

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 239 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02693691
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02693691. Allocation not applicable; no masking; primary purpose treatment. Start 2016-05 (registry gives no type); primary completion 2019-03-31 (actual). Results posted on 2020-08-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CardioMEMS European Monitoring Study for Heart Failure
Acronym
MEMS-HF
Condition
Heart Failure
Intervention (Device)
CardioMEMS HF System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02693691
Content hash
47b1b3c571d73b05679444aeffba7d146edad362b2fd2639dcc8aeb6407a6289